Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:50:21.103Z.
Calculation as of: 2026-10-06T12:50:21.103Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8b4a3eec411172ef5ea6343195523a59a16bbab67eb0b09a3c3cdf82258b1615
EARNINGS YIELD
N/A
Adaptive Biotechnologies Corporation
Market Cap
$4.78B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.50B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.49B
Earnings Yield
7.75%
TTM Avg
5.11%
3Y Avg
3.07%
5Y Avg
3.43%
Market Cap
$5.20B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.20B
Earnings Yield
2.78%
TTM Avg
2.80%
3Y Avg
2.38%
5Y Avg
2.05%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation (ADPT) | $4.78B | N/A | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 0.57% | 0.37% | 0.37% | 0.37% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.49B | 7.75% | 5.11% | 3.07% | 3.43% |
| Erasca, Inc. (ERAS)vs › | $5.11B | N/A | N/A | N/A | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 2.78% | 2.80% | 2.38% | 2.05% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.34B | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
